Contribution of the private sector healthcare service providers to malaria diagnosis in a prevention of re-introduction setting

Abstract

BackgroundSri Lanka is currently in the prevention of re-introduction phase of malaria. The engagement of the private sector health care institutions in malaria surveillance is important. The purpose of the study was to determine the number of diagnostic tests carried out, the number of positive cases identified and the referral system for diagnosis in the private sector and to estimate the costs involved.MethodsThis prospective study of private sector laboratories within the Colombo District of Sri Lanka was carried out over a 6-month period in 2015. The management of registered private sector laboratories was contacted individually and the purpose of the study was explained. A reporting format was developed and introduced for monthly reporting.ResultsForty-one laboratories were eligible to be included in the study and 28 participated by reporting data on a monthly basis. Excluding blood bank samples and routine testing for foreign employment, malaria diagnostic tests were carried out on 973 individuals during the 6-month period and nine malaria cases were identified. In 2015, a total of 36 malaria cases were reported from Sri Lanka. Of these, 24 (67 %) were diagnosed in the Colombo District and 50 % of them were diagnosed in private hospitals.ConclusionsAn equal number of cases were diagnosed from the private sector and government sector in the Colombo District in 2015. The private sector being a major contributor in the detection of imported malaria cases in the country should be actively engaged in the national malaria surveillance system.

A Comparative Analysis of the Outcome of Malaria Case Surveillance Strategies in Sri Lanka in the Prevention of Re-establishment Phase

“…Over the past 7 years since elimination, 30-40% of malaria patients reported in the country were those in whom malaria was suspected and/or detected in the private health sector [7]. It is the practice that when a private hospital, clinic or laboratory suspects or detects a case of malaria, the AMC Headquarters or…”

The Impact, Emerging Needs, and New Research Questions Arising from 12 Years of the Center for the Study of Complex Malaria in India

“…Engagement of private healthcare institutions for malaria elimination programs requires devising uniform policies and platforms, not only for malaria case detection, reporting, and data sharing, but also for training, guidance, and monitoring of malaria diagnostic standards, case management strategies, and adherence to treatment guidelines. 15 , 16 The CSCMi has built capacity and developed infrastructure at several private hospitals including the Steel Authority of India Ltd., IGH in Rourkela, Odisha, a public sector undertaking (PSU) tertiary hospital in Odisha undertaking seminal research in cerebral malaria (CM) pathogenesis as part of the CSCMi; 17 – 19 and at the private multispecialty CWSH in Rourkela, which is leading the DAMaN effectiveness trial described previously. Despite the huge potential and value of incorporating private healthcare institution data, obstacles remain, such as the identification of the private clinics and accessibility of the data.…”

A comparative analysis of the outcome of malaria case surveillance strategies in Sri Lanka in the prevention of re‐establishment phase

“…Over the past 7 years since elimination, 30–40% of malaria patients reported in the country were those in whom malaria was suspected and/or detected in the private health sector [ 7 ]. It is the practice that when a private hospital, clinic or laboratory suspects or detects a case of malaria, the AMC Headquarters or Regional Malaria Offices are informed, and it is the personnel of the AMC who then confirms the malaria diagnosis, provides the medicines free-of-charge and follows up the patient thereafter in accordance with the National Programme’s case management guidelines [ 8 ].…”